STOCK TITAN

Cartesian Growth Corp II (RENEF) SEC Filings

RENEF OTC

Welcome to our dedicated page for Cartesian Growth II SEC filings (Ticker: RENEF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cartesian Growth II's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cartesian Growth II's regulatory disclosures and financial reporting.

Rhea-AI Summary

Cartesian Growth Corporation II and InoBat AS released an investor presentation describing their proposed business combination. The transaction will later be submitted to Cartesian shareholders after a planned Form F-4 registration statement, which will include a proxy statement/prospectus for voting and for issuing securities to InoBat shareholders.

The presentation outlines InoBat’s energy storage business, including a 2,000 m² battery energy storage system (BESS) production facility in Voderady, Slovakia with capacity to scale up to 5 GWh, and a BESS business with 875 MWh delivered or signed. It highlights partnerships, development of sodium-ion battery technology for BESS and low-voltage automotive uses, and notes that investment decisions should be based on the detailed documents to be filed with the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cartesian Growth Corporation II, a Cayman Islands SPAC, reported for the quarter ended June 30, 2026. It has not begun operating activities and continues to seek a Business Combination. Total assets were $38.6 million, including $38.4 million in an interest-bearing Trust Account and $149,017 of cash outside the trust.

Total liabilities were $24.7 million, including warrant liabilities of $1.8 million, related-party convertible promissory notes at fair value of $5.2 million, and deferred underwriting fees of $11.5 million. Shareholders’ deficit was $(24.4 million), and 3,076,094 Class A ordinary shares were classified as subject to possible redemption at an aggregate redemption value of $38.4 million.

For the six months ended June 30, 2026, the company recorded net income of $2.4 million, driven mainly by a $2.7 million non-cash gain from changes in warrant fair value and $0.5 million of trust interest, partially offset by $0.8 million in general and administrative costs. The second quarter alone showed a net loss of $0.7 million. Management disclosed substantial doubt about the ability to continue as a going concern due to limited liquidity and a mandatory liquidation date of August 5, 2027 if no Business Combination closes.

The trust has been significantly reduced by multiple shareholder redemptions tied to charter extensions, and the company was delisted from Nasdaq in July 2025 and is now quoted on the over-the-counter market. On July 24, 2026, it entered into a Business Combination Agreement with InoBat AS valuing InoBat at $1.265 billion, subject to closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Context Capital Management, LLC, together with Michael S. Rosen, William D. Fertig, Charles E. Carnegie and Context Partners Master Fund, L.P., reports that it no longer beneficially owns any Class A ordinary shares of Cartesian Growth Corp II.

The group discloses beneficial ownership of zero Class A ordinary shares, representing 0.0% of the class, based on 8,826,094 Class A ordinary shares outstanding as of July 6, 2026 as reported by the issuer. Each reporting person disclaims membership in a group and disclaims beneficial ownership of any securities except to the extent of any pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

CGC II Sponsor LLC, a 10% owner of Cartesian Growth Corp II, transferred 800,000 Class A ordinary shares to a PIPE investor for no cash consideration in connection with the proposed business combination with InoBat AS. This transaction is reported as an “other acquisition or disposition” (code J). Following the transfer, 4,949,998 Class A ordinary shares are reported as directly held by the sponsor and its affiliated director entity. Pangaea Three-B, LP, which controls the sponsor, and Chairman and Chief Executive Officer Peter Yu may be deemed to share voting and dispositive power over these holdings, while Mr. Yu disclaims beneficial ownership except to the extent of his pecuniary interest. The group also holds Class B ordinary shares that automatically convert into Class A shares on a one-for-one basis at the time of the initial business combination or earlier at the holder’s option.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cartesian Growth Corporation obtained shareholder approval on July 30, 2026 to amend its Charter and extend the SPAC’s Termination Date for completing its initial business combination from August 5, 2026 to August 5, 2027. This extension became effective upon shareholder approval at the extraordinary general meeting.

On the July 6, 2026 record date, 8,826,094 ordinary shares were entitled to vote, with approximately 89.177% represented at the meeting. The Extension Proposal passed with 7,870,808 votes for, and no votes against or abstentions. In connection with the extension, holders of 2,601,058 Class A Ordinary Shares redeemed their shares for cash at approximately $12.50 per share, for an aggregate of $32.5 million, leaving $5.9 million in the Trust Account.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cartesian Growth Corporation II agreed to a business combination with InoBat AS, valuing InoBat at $1,265,000,000, split between $575,000,000 of upfront consideration and up to $690,000,000 of milestone-based earn-outs. Closing is targeted for the fourth quarter of 2026, subject to shareholder and regulatory approvals.

InoBat will form Dutch holding company InoBat N.V. (“ListCo”), which will acquire InoBat and merge CGC into a ListCo subsidiary; CGC shareholders will receive one ListCo share per CGC share, and existing CGC warrants will become ListCo warrants with the same $11.50 exercise price. Earn-out shares, issued at a deemed $10.20 per share, vest only if Project Kamzik is commissioned by December 31, 2027 and if ListCo EBITDA exceeds €47,000,000 and €87,000,000 in specified fiscal years.

The combination includes $77,500,000 of committed capital from PIPE investors and current shareholders and has no minimum-cash condition. Sponsor concessions include forfeiting private warrants, transferring 800,000 CGC Class A shares to an institutional PIPE investor, and converting $9,200,000 of loans into ListCo preference shares and PIPE warrants. Key closing conditions include effectiveness of a Form F-4, Nasdaq listing of ListCo, antitrust and foreign-investment clearances, completion of the PIPE financing, and delivery of shareholder undertakings covering at least 90% of InoBat’s shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Cartesian Growth II (RENEF) SEC filings are available on StockTitan?

StockTitan tracks 6 SEC filings for Cartesian Growth II (RENEF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cartesian Growth II (RENEF)?

The most recent SEC filing for Cartesian Growth II (RENEF) was filed on August 14, 2026.